A Colorado government advisory board is recommending that the state expand its novel regulated psychedelics market by providing access to ibogaine in addition to psilocybin and psilocin, which are currently allowed. At a meeting of the Natural Medicine Program Advisory Board on Thursday, members discussed the future of Colorado’s psychedelics program, which launched after voters…...
Free Membership Required
You must be a Free member to access this content.
Already a member? Log in here
